Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI could cut prostate MRI time while keeping accuracy

NCT ID NCT06094322

First seen Nov 19, 2025 · Last updated Jun 22, 2026 · Updated 36 times

Summary

This study tested whether new deep learning (AI) technology can make prostate MRI scans faster while still finding suspicious nodules. Researchers compared standard MRI sequences with faster, AI-enhanced versions in 34 adults referred for prostate MRI. The goal was to see if the quicker scans could match standard ones in detecting potential cancer, which could reduce exam time and improve patient comfort.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Hospitalier Universitaire d'Amiens

    Amiens, Picardie, 80000, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Deep learning-enhanced MRI sequences

What this could lead to

If successful, this could lead to faster, more comfortable prostate MRI exams without losing diagnostic accuracy.

What could go wrong

This is a small, early-stage study with only 34 participants, so results may not apply to all patients. The AI technique may not detect all cancers as reliably as standard scans.

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.